A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
NCT00234520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225
Last updated 2019-08-02
Summary
The aim of the study is to compare the risk of acromegaly patients developing valvular regurgitation when receiving lanreotide or octreotide
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2005-02-18
- Completion
- 2005-02-18
Countries
- Belgium
- Czechia
- Denmark
- France
- Hungary
- Italy
- Poland
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation
NCT03154034 ·Status: COMPLETED
-
Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
NCT04613193 ·Status: RECRUITING ·Phase: NA
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aortic Stenosis Evaluated Via Modern Ballistocardiography and Seismocardiography
NCT04231201 ·Status: SUSPENDED
-
Impact of Predilatation Between Self-expanding Valves
NCT04157920 ·Status: COMPLETED ·Phase: NA
-
The Long-term Course of Moderate Tricuspid Regurgitation
NCT06169345 ·Status: COMPLETED
-
Comparison of Blood and Crystalloid Cardioplegia
NCT01941420 ·Status: COMPLETED
-
Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction
NCT03667365 ·Status: TERMINATED ·Phase: NA
-
Dapagliflozin After Transcatheter Aortic Valve Implantation
NCT04696185 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcome of Patients With Low-gradient Severe Aortic Stenosis
NCT02010177 ·Status: SUSPENDED
-
Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
NCT00294775 ·Status: UNKNOWN ·Phase: PHASE3
-
Pressure Gradient vs. Flow Relationships in Patients With Symptomatic Valvular Aortic Stenosis
NCT05580237 ·Status: COMPLETED
-
Clinical Trial in China
NCT05580952 ·Status: UNKNOWN ·Phase: NA
-
Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT04333875 ·Status: COMPLETED
-
Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis
NCT06894550 ·Status: RECRUITING ·Phase: NA
-
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation
NCT06805253 ·Status: RECRUITING
-
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
NCT06595992 ·Status: RECRUITING
-
Aortic Stenosis: Determinants and Prognostic Value of Preoperative Left Ventricular Remodeling After Valvular Replacement
NCT03411304 ·Status: ACTIVE_NOT_RECRUITING
-
Diastolic Dysfunction in Aortic Regurgitation
NCT00976625 ·Status: COMPLETED ·Phase: NA
-
Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation
NCT02910349 ·Status: COMPLETED
-
Saline-induced Distal to Aortic Coronary Pressure Ratio vs. Resting and Hyperemic Indices of Coronary Artery Stenosis Severity
NCT04284345 ·Status: COMPLETED ·Phase: NA
-
Short- and Medium-term Results of New Generation Aortic
NCT05055089 ·Status: UNKNOWN
-
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
NCT06427304 ·Status: RECRUITING
-
Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation
NCT07042360 ·Status: RECRUITING
-
Online Videodensitometric Assessment of Aortic Regurgitation in the Cath-Lab
NCT04047082 ·Status: UNKNOWN